Aurobindo Pharma Ltd
May 29, 2012 at 11:11 | Source: CNBC-TV18
May 29, 2012 at 08:28 | Source: CNBC-TV18
May 25, 2012 at 15:54 | Source: CNBC-TV18
May 23, 2012 at 12:21 | Source: Moneycontrol.com
May 18, 2012 at 12:58 | Source: Moneycontrol.com
News across the web »
May 29, 2012 at 09:21 | Source: Economic Times
May 19, 2012 at 22:41 | Source: The Hindu BusinessLine
May 19, 2012 at 02:01 | Source: Business Standard
May 17, 2012 at 22:32 | Source: The Hindu BusinessLine
May 17, 2012 at 17:55 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
(RTTNews) - Manufacturer of generic pharmaceuticals and active pharmaceutical ingredients Aurobindo Pharma Ltd. said it had received final approval for its tentatively approved ANDAs for Nevirapine tablets 200mg covered under ANDA 077521 and Nevirapine ...
May 23, 2012 at 06:33 | Source: RTT News
Aurobindo Pharma Ltd has now announced with reference to the date of the Board Meeting to consider Audited Financial Results on May 29, 2012, that at the said Board meeting the Board will also consider recommendation of Dividend, if any, for the year 2011-12.
May 21, 2012 at 06:21 | Source: equitybulls.com
Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval from the US Food and Drug Administration (USFDA) to launch a low-cost version of blood-thinning drug Plavix in the US. The drug is used to reduce the risk of heart attack and stroke.
May 27, 2012 at 06:57 | Source: Business Standard
The Aurobindo Pharma Ltd stock was trading at Rs.103.80, down by Rs.2.45 or 2.31%. The stock hit an intraday high of Rs.104.90 and low of Rs.102. The total traded quantity was 0.53 lakhs compared to 2 week average of 1.03 lakhs.
May 16, 2012 at 07:17 | Source: equitybulls.com
Apart from Mylan, Prinston Inc., Hetero Labs Ltd III, Strides, Cipla and Aurobindo Pharma have gained approval to market their generic versions of Viramune. According to IMS Health, Plavix generated U.S. revenues of approximately $6.7 billion for the 12 ...
May 24, 2012 at 21:41 | Source: NASDAQ
Mumbai: Drug maker Dr Reddy’s Laboratories Ltd (DRL) said on Friday that it had launched a generic version of the world’s second largest selling drug brand Plavix, the blood thinner drug sold by of Bristol Myers Squibb and Sanofi SA, in the US under ...
May 18, 2012 at 09:09 | Source: Livemint.com
Apart from Mylan, Prinston Inc., Hetero Labs Ltd III, Strides, Cipla and Aurobindo Pharma have gained approval to market their generic versions of Viramune. According to IMS Health, Plavix generated U.S. revenues of approximately $6.7 billion ...
May 24, 2012 at 21:05 | Source: Yahoo Finance
Gate Pharmaceuticals, Mylan Pharmaceuticals Inc.andTeva Pharmaceuticals Industries Ltd. received FDA approval for 300 mg clopidogrel, and Apotex Corp., Aurobindo Pharma Ltd., Mylan, Roxane Laboratories, Sun Pharma, Teva and Torrent ...
May 18, 2012 at 01:39 | Source: TMCnet
Teva, Mylan Inc. (NYSE: MYL), Apotex Corporation, Roxane Laboratories Inc. of the US, India's Sun Pharmaceutical Industries Ltd. (BSE: 524715) Aurobindo Pharma Ltd. (BSE: 524804) and Torrent Pharmaceuticals, obtained marketing approval for 75 milligram ...
May 20, 2012 at 09:36 | Source: Globes - Israel Business Arena
News ) and Teva Pharmaceutical Industries Ltd. (TEVA: News )are the companies that have gained FDA approval for 300 milligram Clopidogrel. Apotex Corp., Aurobindo Pharma, Mylan Pharmaceuticals, Roxane Laboratories, Sun Pharma, Teva Pharmaceuticals ...
May 18, 2012 at 04:02 | Source: RTT News